Anika Therapeutics Ownership | Who Owns Anika Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Anika Therapeutics Ownership Summary


Anika Therapeutics is owned by 88.51% institutional investors, 4.89% insiders, and 6.60% retail investors. Trigran investments is the largest institutional shareholder, holding 14.21% of ANIK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnika Therapeutics88.51%4.89%6.60%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryMedical Device Stocks52.08%10.61%37.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Trigran investments2.04M14.21%$21.55M
Blackrock1.61M10.93%$40.70M
Blackrock funding, inc. /de1.53M10.66%$16.17M
Caligan partners lp1.44M9.72%$23.62M
Vanguard group765.27K5.18%$12.60M
Dimensional fund advisors lp657.36K4.45%$10.82M
Acadian asset management575.64K4.02%$6.08M
Boothbay fund management529.50K3.69%$5.60M
Renaissance528.52K3.58%$8.70M
Morgan stanley501.99K3.42%$12.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp1.44M5.98%$23.62M
Trigran investments2.04M3.74%$21.55M
Alta fundamental advisers454.94K2.47%$4.81M
Stonepine capital management190.59K1.98%$2.02M
Cove street capital74.10K1.15%$783.97K
Capital management corp /va325.55K0.96%$5.36M
Diker management56.84K0.56%$601.36K
Ironwood investment management28.36K0.15%$300.06K
Virtus fund advisers2.72K0.14%$44.84K
Boothbay fund management529.50K0.11%$5.60M

Top Buyers

HolderShares% AssetsChange
Jpmorgan chase82.49K0.00%66.98K
Ubs group68.72K0.00%61.18K
Blackrock1.61M0.00%45.79K
Acadian asset management575.64K0.01%36.03K
Capital management corp /va325.55K0.96%35.20K

Top Sellers

HolderShares% AssetsChange
Morgan stanley501.99K0.00%-199.74K
Meros investment management, lp---173.49K
Franklin resources---133.41K
Segall bryant & hamill---108.80K
Riverwater partners---102.00K

New Positions

HolderShares% AssetsChangeValue
Skopos labs6.95K0.01%6.95K$73.51K
Glenmede investment management, lp1.22K0.00%1.22K$12.91K
Srs capital advisors308.000.00%308.00$3.26K
Raymond james financial80.00-80.00$847.00
Clearstead advisors44.00-44.00$466.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-3.00
Assetmark-3.00
Ifp advisors-4.00
Hexagon capital partners-8.00
Rothschild investment-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025101-6.48%12,685,0363.92%881.21%5412.50%31-24.39%
Mar 31, 2025109-1.80%12,677,8191.18%881.23%48-11.11%427.69%
Dec 31, 2024110-10.57%12,521,428-4.37%841.08%538.16%39-18.75%
Sep 30, 20241236.96%13,093,709-1.09%881.11%49-2.00%48-
Jun 30, 2024113-6.61%13,237,819-1.18%901.08%49-14.04%4714.63%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF439.41K3.10%-
Vanguard Total Stock Mkt Idx Inv429.93K2.98%-9.48K
iShares Russell 2000 ETF298.45K2.07%-5.67K
CMC SMID249.46K1.74%32.73K
Vanguard Institutional Extnd Mkt Idx Tr164.18K1.14%-74.81K
Fidelity Small Cap Index130.54K0.91%-
CMC All-Cap Growth126.64K0.88%34.85K
Franklin Mutual Small-Mid Cap Val A120.97K0.83%-
DFA US Targeted Value I112.34K0.78%-
iShares Russell 2000 Value ETF107.45K0.75%80.00

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

ANIK Ownership FAQ


Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 88.51%, followed by 4.89% insiders and 6.60% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 52.08%, which Anika Therapeutics exceeds.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Trigran investments (2.04M shares, 14.21%), Blackrock (1.61M shares, 10.93%), and Blackrock funding, inc. /de (1.53M shares, 10.66%). Together, they hold 35.81% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.98% of its assets in 1.44M Anika Therapeutics shares, valued at 23.62M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anika Therapeutics shares, with 3.10% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools